Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations
European Journal of Clinical Microbiology and Infectious Diseases
2026
Li X.J.
Mitigating Tuberculosis Drug-induced Liver Injury: The Role of Moringa oleifera and Other Herbal Extracts
International Journal of Mycobacteriology
1 April 2025
Mawarti H.
Preparation of silymarin enriched extract (Silybum marianum) using macroporous resins: Adsorption/desorption characteristics, quantitative analysis by HPLC and UPLC
Microchemical Journal
December 2024
Shafiei A.
Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis
Biomolecules
December 2024
Raqib R.
Open Access
Novel strategies based on natural products and synthetic derivatives to overcome resistance in Mycobacterium tuberculosis
European Journal of Medicinal Chemistry
5 April 2024
Niculescu A.G.
Clinical guidelines. Drug-induced liver injury (DILI) in adults
Experimental and Clinical Gastroenterology
2024
Drapkina O.M.
Open Access
Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: Present advancements and future prospects
Phytotherapy Research
January 2024
Singh D.
Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
Open Life Sciences
1 January 2024
Kmail A.
Open Access
Promising hepatoprotective agents from the natural sources: a study of scientific evidence
Egyptian Liver Journal
December 2023
Pandey B.
Open Access
Systematic review and network meta-analysis of efficacy and safety of interventions for preventing anti-tuberculosis drug induced liver injury
Scientific Reports
December 2023
Akkahadsee P.
Open Access
An Insight into the Hepatoprotective Activity and Structure-activity Relationships of Flavonoids
Mini Reviews in Medicinal Chemistry
February 2023
Majee C.
The Effectiveness of Silymarin in the Prevention of Anti‑tuberculosis Drug‑induced Hepatotoxicity: A Randomized Controlled Clinical Trial
International Journal of Preventive Medicine
January 2023
Talebi A.
Open Access
Silymarin: a review on paving the way towards promising pharmacological agent
International Journal of Food Properties
2023
Akhtar M.N.
Open Access
Hepatoprotective drugs for prevention of liver injury resulting from anti-tuberculosis treatment: A meta-analysis of cohort studies
Infectious Medicine
September 2022
Wang D.
Open Access
Mechanistic Insights into the Pharmacological Significance of Silymarin
Molecules
August 2022
Wadhwa K.
Open Access
Effect of probiotics combined with food drug homologous products in ameliorating anti-tuberculous drugs-induced liver injury and intestinal dysbiosis in mice
Chinese Journal of Microecology
June 2022
Xia X.Y.
Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients
Frontiers in Pharmacology
20 April 2022
Chen Q.
Open Access
Clinical Studies of Silymarin as a Protective Agent Against Liver Damage Caused by Anti-TB Drugs, Methotrexate, and in Cases of Chronic Hepatitis C and Diabetes Mellitus
Pharmacognosy Journal
March-April 2022
Adelina J.A.M.
Open Access
Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals
Medcomm
December 2021
Fatima S.
Open Access
Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
Chinese Medicine United Kingdom
December 2021
Zhou Y.
Open Access
The Effect of acetyl-L-carnitine, Alpha-lipoic Acid, and Coenzyme Q10 Combination in Preventing Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized, Double-blind, Placebo-controlled Clinical Trial
Iranian Journal of Pharmaceutical Research
July 2021
Hakimizad R.
Efficacy and safety of silybin for the prevention of antituberculosis drug-induced liver injury: A meta-analysis
China Tropical Medicine
18 May 2021
Guan B.